Quantcast

Latest Glycopeptide antibiotics Stories

2014-09-08 08:30:48

Data demonstrate potent, broad spectrum activity against gram-positive and gram-negative bacteria, including resistant organisms that cause skin infections NEW YORK, Sept. 8, 2014 /PRNewswire/ -- Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of Locilex® (pexiganan cream 0.8%), and research collaborators, today announced updated data from a microbiology study of Locilex® were presented at the 54th...

2014-09-03 04:21:58

VIENNA, September 3, 2014 /PRNewswire/ -- New US Subsidiary to be located in the Philadelphia Area Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant gram-positive and gram-negative pathogens, today announced the appointment of Dr Colin Broom as Chief Executive Officer (CEO). Current CEO Ralf Schmid will remain a member of the...

2014-07-07 12:28:56

To Effectively Compete with Current Anti-MRSA Therapies, Emerging Agents Will Need to be Amenable to Outpatient Use, According to Findings from Decision Resources Group BURLINGTON, Mass., July 7, 2014 /PRNewswire/ -- Decision Resources Group finds that, although vancomycin continues to be the standard-of-care for infections caused by methicillin-resistant Staphylococcus aureus (MRSA), there is growing concern among infectious disease (ID) specialists over rising vancomycin minimum inhibitory...

New Antibiotics Show Effectiveness In Treating MRSA Infections
2014-06-05 07:34:39

Lawrence LeBlond for redOrbit.com - Your Universe Online Two separate studies published this week in the New England Journal of Medicine are paving the way for more effective treatments in deadly methicillin-resistant Staphylococcus aureus (MRSA) infections. DALBAVANCIN The first study comes from a team led by Helen Boucher, MD, Associate Professor of Medicine at Tufts Medical Center. That study reports on an antibiotic called dalbavancin (Dalvance) that has shown just as effective...

2014-04-03 12:27:08

Lipoglycopeptides Dalvance and Oritavancin Will Find Favorable Uptake as Convenient Outpatient Anti-MRSA Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., April 3, 2014 /PRNewswire/ -- Decision Resources Group finds that following its launch, Cubist's second generation oxazolidinone Sivextro will be highly differentiated from other anti-MRSA (methicillin-resistant Staphylococcus aureus) agents for the treatment of complicated skin and skin structure infections...

2013-12-14 23:01:35

MarketResearchReports.Biz announces addition of new report “Skin And Skin Structure Infections (SSSI) Caused By Bacteria 2013” to its database. Visit http://www.marketresearchreports.biz/analysis-details/skin-and-skin-structure-infections-sssi-caused-by-bacteria-pipeline-review-h2-2013. Albany, NY (PRWEB) December 14, 2013 Global Markets Directs, 'Skin And Skin Structure Infections (SSSI) Caused By Bacteria Pipeline Review, H2 2013', provides an overview of the indications...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related